Halozyme Therapeutics HALO Earnings Call Transcripts

NASDAQ HALO
$102.98 +0.06 (+0.06%)
At close: Nov 10, 2026 · 4:00 PM EST
12 earnings calls on file for Halozyme Therapeutics, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Halozyme Therapeutics Q2 2026 Earnings Call

Aug 6, 2026 6,452 words · 28 min read
  • Tram BuiVice President of Investor Relations
  • Dr. Helen TorleyPresident and Chief Executive Officer
  • Darren SnellgroveChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Halozyme Therapeutics Earnings Call Transcripts

Calls12
LatestAug 6, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 12 Halozyme Therapeutics transcripts Register to get access to Halozyme Therapeutics’s earnings call transcripts.